Financial Perspectives’s Edwards Lifesciences EW Stock Holding History

Financial Perspectives’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.61K	Hold	62	–	–	﹤0.01%	600
2026 Q1	$4.96K	Hold	62	–	–	﹤0.01%	587
2025 Q4	$5.29K	Hold	62	–	–	﹤0.01%	584
2025 Q3	$4.82K	Hold	62	–	–	﹤0.01%	586
2025 Q2	$4.85K	Hold	62	–	–	﹤0.01%	579
2025 Q1	$4.49K	Hold	62	–	–	﹤0.01%	577
2024 Q4	$4.59K	Hold	62	–	–	﹤0.01%	575
2024 Q3	$4.09K	Hold	62	–	–	﹤0.01%	538
2024 Q2	$5.73K	Hold	62	–	–	﹤0.01%	504
2024 Q1	$5.92K	Sell	62 -67	-52%	-$5.63K	﹤0.01%	497
2023 Q4	$9.85K	Hold	129	–	–	﹤0.01%	470
2023 Q3	$8.95K	Buy	129 +62	+93%	+$4.98K	﹤0.01%	459
2023 Q2	$6.33K	Hold	67	–	–	﹤0.01%	490
2023 Q1	$5.55K	Hold	67	–	–	﹤0.01%	501
2022 Q4	$5.01K	Hold	67	–	–	﹤0.01%	511
2022 Q3	$5.55K	Hold	67	–	–	﹤0.01%	496
2022 Q2	$6.38K	Hold	67	–	–	﹤0.01%	488
2022 Q1	$7.9K	Hold	67	–	–	﹤0.01%	489
2021 Q4	$8.7K	Hold	67	–	–	﹤0.01%	457
2021 Q3	$7.6K	Hold	67	–	–	﹤0.01%	469
2021 Q2	$6.95K	Sell	67 -5,548	-99%	-$523K	﹤0.01%	499
2021 Q1	$67K	Buy	5,615 +5,548	+8,281%	+$469K	﹤0.01%	537
2020 Q4	$6.12K	Hold	67	–	–	﹤0.01%	455
2020 Q3	$5.36K	Hold	67	–	–	﹤0.01%	414
2020 Q2	$4.64K	Buy	+67	New	+$4.76K	﹤0.01%	414

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Financial Perspectives's EW Position: Q2 2026 in Review

Financial Perspectives held its Edwards Lifesciences (EW) position steady in Q2 2026 at 62 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #600.

Financial Perspectives first reported a position in EW in Q2 2020 and has held it in 25 quarters since. The position peaked at $67K in Q1 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Financial Perspectives held 62 shares of Edwards Lifesciences worth $5.61K as of Q2 2026.
Financial Perspectives left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Financial Perspectives's portfolio in Q2 2026, its #600 holding.
Financial Perspectives first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 25 quarters since.
Financial Perspectives's Edwards Lifesciences position peaked at $67K in Q1 2021.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.